Four PEG-Driven GARP Winners for the Uncertainty of November 2025
Four PEG-driven GARP picks emerge as compelling options amid market turmoil, with ALL, SANM, PAHC and ENS highlighted for their strong growth metrics.
Phibro ( PAHC ) Upgraded to Strong Buy: Here's What You Should Know
Phibro (PAHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
PAHC or BSX: Which Is the Better Value Stock Right Now?
PAHC vs. BSX: Which Stock Is the Better Value Option?
4 Stocks Trading Near 52-Week High With More Upside Potential
Stocks like PAHC, ATRO, COMM and HRTG are seeing price strength and have a high chance of carrying the momentum forward.
Best Momentum Stock to Buy for Nov. 20th
PAHC, SHIP and BCAL made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 20, 2025.
Best Income Stocks to Buy for Nov. 20th
SHIP, PAHC and FCFS made it to the Zacks Rank #1 (Strong Buy) income stocks list on November 20, 2025.
New Strong Buy Stocks for Nov. 20: CMC, BCAL, and More
CMC, BCAL, FCFS, PAHC and SHIP have been added to the Zacks Rank #1 (Strong Buy) List on November 20, 2025.
Why Phibro Animal Health ( PAHC ) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Phibro Animal Health ( PAHC ) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Phibro Animal Health ( PAHC ) Q1 Earnings and Revenues Top Estimates
Phibro (PAHC) delivered earnings and revenue surprises of +23.73% and +2.60%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Can Strength in Rental Business Drive INFU Stock Before Q3 Earnings?
InfuSystem eyes third-quarter 2025 gains as rental contracts and ERP upgrades boost margins across Patient Services and Device Solutions.
EW Stock Gains on Q3 Earnings and Revenue Beat, Margins Crash
Edwards Lifesciences Q3 earnings and sales beat estimates on robust TAVR and TMTT growth, though margins take a sharp hit.
New Strong Buy Stocks for Oct. 31: PMT, NWG, and More
PMT, NWG, PAHC, CNC and ACNB have been added to the Zacks Rank #1 (Strong Buy) List on October 31, 2025.
ALGN Stock Up on Q3 Earnings and Revenue Beat, Margins Crash
Align Technology jumps 15% after Q3 earnings and revenues beat estimates, though steep margin declines weigh on results.
Sanuwave Health Inc. ( SNWV ) to Report Q3 Results: Wall Street Expects Earnings Growth
Sanuwave Health (SNWV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Phibro Animal Health ( PAHC ) Earnings Expected to Grow: What to Know Ahead of Q1 Release
Phibro (PAHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CHE Stock Falls on Q3 Earnings and Revenue Miss, Margins Crash
Chemed's Q3 miss sends shares lower as shrinking margins and weaker EPS overshadow steady revenue gains from VITAS and Roto-Rooter.
Is Phibro ( PAHC ) a Solid Growth Stock? 3 Reasons to Think "Yes"
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
LH Q3 Earnings Beat, Revenues Miss, '25 Sales View Cut, Stock Down
Labcorp's Q3 earnings beat forecasts and margins improve, but a trimmed 2025 sales outlook sends shares down.
Are Investors Undervaluing Phibro Animal Health ( PAHC ) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Brainsway Ltd. Sponsored ADR ( BWAY ) Hits Fresh High: Is There Still Room to Run?
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PAHC vs. BSX: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health ( PAHC Quick QuotePAHC - ) and Boston Scientific ( BSX Quick QuoteBSX - ) . But which of these two companies is the best option for those looking for undervalued stocks?
ITGR Shares Down Despite Q3 Earnings & Revenues Beat Estimates
Integer Holdings posts strong Q3 results with earnings and revenue beat, but shares plunge on a softer 2026 growth outlook.
Here's Why Phibro Animal Health ( PAHC ) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ISRG Stock Gains on Q3 Earnings & Revenue Beat, Gross Margin Declines
Intuitive Surgical's shares jump 17% after Q3 earnings and revenues beat expectations, fueled by surging da Vinci 5 placements and strong global procedure growth.
Boston Scientific Beats on Q3 Earnings, Raises 2025 View, Stock Up
BSX posts strong Q3 with 19% EPS growth, lifts 2025 sales and EPS outlook as shares edge higher.
Thermo Fisher's Q3 Earnings & Revenues Top Estimates, Stock Climbs
TMO delivers robust Q3 results, fueled by margin growth, new launches and AI-focused strategic initiatives.
Phibro Animal Health Corporation ( PAHC ) Hits Fresh High: Is There Still Room to Run?
Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
4 Stocks Trading Near 52-Week High With More Upside Potential
Stocks like M, PAHC, WDC and ATRO are seeing price strength and have a high chance of carrying the momentum forward.
Quest Diagnostics Stock Up on Q3 Earnings & Revenue Beat, Margins Rise
DGX posts a strong Q3 with revenues and EPS beating estimates, higher margins and an upbeat full-year outlook.
Here's Why Phibro Animal Health ( PAHC ) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Abbott's Q3 Earnings Meet Estimates, Revenues Up Y/Y, Stock Climbs
ABT's Q3 earnings meet expectations as revenues climb 6.9% year over year, driven by double-digit gains in Medical Devices.
PAHC or BSX: Which Is the Better Value Stock Right Now?
PAHC vs. BSX: Which Stock Is the Better Value Option?
Neogen Q1 Earnings Miss Estimates, Revenues Beat, Stock Climbs
NEOG's Q1 earnings decline 42.9% year over year, while revenues of $209.2 million top the consensus mark.
The Launch of Foot and Ankle Trauma Solutions May Boost ZBH Stock
Zimmer Biomet expands its foot & ankle trauma lineup with Gorilla Pilon Fusion & Phantom TTC Trauma Nail launches.
Why Phibro Animal Health ( PAHC ) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should You Continue to Hold Bio-Techne Stock in Your Portfolio?
TECH drives growth via acquisitions, international strength and innovation. However, it faces macro pressures and rising competition.
Thermo Fisher's New R&D Alliance With AstraZeneca May Lift Its Stock
TMO joins AstraZeneca's BioVentureHub to boost R&D, innovation and life science access.
Reasons to Add Omnicell Stock to Your Portfolio Right Now
OMCL's expanding SaaS portfolio, overseas growth plans, and solid balance sheet position it for sustained momentum despite rising competition.
New Strong Buy Stocks for October 7th
ALHC, STNE, EGAN, PAHC and MTG have been added to the Zacks Rank #1 (Strong Buy) List on October 7, 2025.
Best Income Stocks to Buy for October 7th
MTG, PAHC and ICAGY made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 7, 2025.
CLPT Expands Into Robotic System Supporting Cell and Gene Therapies
ClearPoint's new Robotic Neuro-Navigation System merges proven software with KUKA robotics to boost precision in cell and gene therapy delivery.
BRKR Shares Climb After Securing New Orders for Its NMR Systems
Bruker stock climbs after securing $10M in federally funded NMR orders from top U.S. research institutions.
ILMN Stock Set to Benefit From the Launch of New BioInsight Division
Illumina launches BioInsight to harness multiomic data, accelerate drug discovery, and boost disease diagnosis.
HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests
Hologic's shares rise after receiving FDA clearance and CE mark for its rapid molecular GI assays on the Panther Fusion platform.
ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves
AngioDynamics posts narrower-than-expected Q1 loss, 12% revenue growth and margin gains. it also raises FY26 sales outlook, sending shares higher.
Why Phibro Animal Health ( PAHC ) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
New Strong Buy Stocks for September 30th
UGP, PDS, FUTU, PAHC and PGY have been added to the Zacks Rank #1 (Strong Buy) List on September 30, 2025.
Bio-Techne Stock Climbs on Advances in Spatial Biology Solutions
TECH shares rise as advances in RNAscope and COMET spotlight new roles in lymphoid malignancy diagnostics.
